UBS AM’s VivoSim Labs VIVS Stock Holding History

UBS AM’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-164	Closed	-$87.5K	–	2607
2017 Q3	$87.5K	Hold	164	–	–	﹤0.01%	2373
2017 Q2	$104K	Hold	164	–	–	﹤0.01%	2338
2017 Q1	$125K	Hold	164	–	–	﹤0.01%	2272
2016 Q4	$134K	Sell	164 -123	-43%	-$97.6K	﹤0.01%	2208
2016 Q3	$261K	Hold	287	–	–	﹤0.01%	2338
2016 Q2	$256K	Hold	287	–	–	﹤0.01%	2304
2016 Q1	$149K	Sell	287 -2	-0.7%	-$1.02K	﹤0.01%	2510
2015 Q4	$173K	Hold	289	–	–	﹤0.01%	2573
2015 Q3	$186K	Buy	289 +45	+18%	+$34.2K	﹤0.01%	2514
2015 Q2	$221K	Buy	244 +79	+48%	+$88.4K	﹤0.01%	2539
2015 Q1	$140K	Buy	165 +15	+10%	+$20.7K	﹤0.01%	2552
2014 Q4	$261K	Hold	150	–	–	﹤0.01%	2319
2014 Q3	$229K	Hold	150	–	–	﹤0.01%	2303
2014 Q2	$301K	Hold	150	–	–	﹤0.01%	2182
2014 Q1	$275K	Buy	150 +14	+10%	+$32.5K	﹤0.01%	2242
2013 Q4	$362K	Buy	+136	New	+$267K	﹤0.01%	2005

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS AM's VIVS Position: Q4 2017 in Review

UBS AM sold out of VivoSim Labs (VIVS) in Q4 2017, closing a stake of 164 shares — an estimated $87.5K sold.

UBS AM first reported a position in VIVS in Q4 2013 and held it in 16 quarters. The position peaked at $362K in Q4 2013. 123 funds tracked by Wall St. Rank hold VIVS as of Q4 2017.

UBS AM reported no remaining VivoSim Labs position as of Q4 2017 after selling out during the quarter.
UBS AM sold 164 VivoSim Labs shares in Q4 2017, an estimated $87.5K.
UBS AM first reported a position in VivoSim Labs in Q4 2013 and held it in 16 quarters.
UBS AM's VivoSim Labs position peaked at $362K in Q4 2013.
123 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2017.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.